研究実績

A Phase II Trial of Trastuzumab Combined with Irinotecan in Patients with Advanced HER2-positive Chemo-refractory Gastric Cancer: OGSG1203 (HERBIS-5)

Daisuke Sakai, Junji Kawada, Ryohei Kawabata, Kazuhiro Nishikawa, Tomono Kawase, Yoshio Oka, Naotoshi Sugimoto, Takeshi Shimizu, Junichi Nishijima, Hiroko Hasegawa, Shunji Endo, Yutaka Isozaki, Yutaka Kimura, Jin Matsuyama, Yukinori Kurokawa, Toshio Shimokawa, Kazumasa Fujitani, Taroh Satoh Korean Cancer Association 2016 , Seoul, 16-17 June 2016

前の記事 次の記事 一覧ページへ戻る